PER 2.50% 8.2¢ percheron therapeutics limited

update: ms drug death, selling pressure possible, page-6

  1. 723 Posts.
    lightbulb Created with Sketch. 129
    re: update: ms drug death Hi Mark,

    It is quite possible that ATL1102 is not a potential cause of PML. However, the point I made in my earlier posts is that ANP now have an obligation to prove this. And proving that there is no link between ATL1102 and PML may prove to be a costly and time consuming business.

    Obviously, if ATL1102 is proven to be unambiguously safe re PML and effective re MS, then ANP have a blockbuster on their hands. But neither the saftey re PML (despite the succuss of phase 1) nor the efficancy of ATL1102 has been clinically proven, so this is a very big 'if'.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.